PITCH SPEAKERS

Akinori Mochizuki

Vetanic Inc.

CEO

Dr. Mochizuki has about 30 years of work experience in pharmaceutical industry; covering from basic science such as molecular and cellular biology, in vivo pharmacology, drug repositioning, CMC and aseptic product development, to various business skills including business development, intellectual property management on top of corporate management. After graduated from Tokyo University of Pharmacy and Life Sciences, he started his career at pharmaceutical company along with obtaining Ph. D. degree in Medicine at Toho University School of Medicine, and he then moved to well-known Japanese biotech venture company, where he acquired most of his business skills as an executive officer and CSO.

Vetanic is committed to provide an impact on human life through achieving high Quality Of Animal Life. Our innovative animal stem cell therapy is derived from iPS cells, one of the deepest biotech technologies from Japan, and will open an era of donor free, sustainable, and affordable global standard regenerative medicine.